Our Core Strengths in Stem Cell Science
Human embryonic stem cells (hESCs) provide clinical scientists with the unprecedented opportunity to economically produce human cell types, on an industrial scale, for the treatment of diseases that have avoided treatment using available medical technologies. This is because hESCs can be manipulated in the laboratory to grow in great numbers and become the types of cells clinicians need to treat these diseases.
However, hESCs must be cultured carefully to result in pure cultures of specific, therapeutic cell types. The end product must be free from exposure to non-human biological materials and must pass rigorous functional and safety tests to be acceptable for use in humans.
These technologies involve developing manufacturing methods that expose hESCs to highly specific chemicals under highly specific physical conditions and time periods and causing them to grow and change to the therapeutic cells sought by the medical community. Our scientists have also developed methods of packaging and applying these cells so doctors can effectively use them to treat patients in need. These technologies, protocols, and methods are strictly compliant with the requirements set forth by regulatory authorities, including manufacture under current good manufacturing practice (cGMP) regulations.